Annalisa Astolfi

Employment

• University of Bologna Associate Professor
  2025 - Present
• University of Bologna Assistant Professor
  2022 - 2025
• University of Ferrara Assistant Professor
  2019 - 2022
• University of Bologna Staff Scientist
  2008 - 2019

Education

• University of Bologna PhD degree in Oncology
  2002 - Present
• University of Bologna Degree in Biological Sciences
  1998 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (292)

• Genome-Wide Single-Nucleotide Polymorphism (SNP)-based Profiling of Loss of Heterozygosity Reveals Distinct Molecular Subgroup-Specific Patterns in Gastrointestinal Stromal Tumors (GIST)
  Laboratory Investigation 2026 DOI: 10.1016/j.labinv.2026.106148
  +Save
• Validation of an Automated Cell Counter Method for HLA-DR and CD3 Expression in Cells Obtained from Low Volume Human Tears
  Diagnostics 2025 DOI: 10.3390/diagnostics15091124
  +Save
• Ocular Surface Microbiota and Corneal Transplant Outcome: Is There a Link?
  Biomedicines 2025 DOI: 10.3390/biomedicines13040972
  +Save
• Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches
  Biomolecules 2025 DOI: 10.3390/biom15020265
  +Save
• miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma
  Cancers 2024 DOI: 10.3390/cancers16030591
  +Save
• Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas
  Biomedicines 2023 DOI: 10.3390/biomedicines11123290
  +Save
• Preclinical Models of Visceral Sarcomas
  Biomolecules 2023 DOI: 10.3390/biom13111624
  +Save
• SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update
  Genes 2023 DOI: 10.3390/genes14030646
  +Save
• The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells
  International Journal of Molecular Sciences 2023 DOI: 10.3390/ijms24054424
  +Save
• Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK)
  International Journal of Molecular Sciences 2023 DOI: 10.3390/ijms24043743
  +Save
• Genomic Characterization of Rare Primary Cardiac Sarcoma Entities
  Diagnostics 2023 DOI: 10.3390/diagnostics13020214
  +Save
• A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes
  Clinical Epigenetics 2023 DOI: 10.1186/S13148-023-01441-9
  +Save
• SRF Rearrangements in Soft Tissue Tumors with Muscle Differentiation
  Biomolecules 2022 DOI: 10.3390/biom12111678
  +Save
• miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs
  International Journal of Molecular Sciences 2022 DOI: 10.3390/ijms232012248
  +Save
• Undetected KIT and PDGFRA mutations: an under-recognised cause of gastrointestinal stromal tumours incorrectly classified as wild-type
  Pathology 2022 DOI: 10.1016/j.pathol.2022.05.004
  +Save
• CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
  Cancers 2022 DOI: 10.3390/cancers14051306
  +Save
• C5 and SRGAP3 Polymorphisms Are Linked to Paediatric Allergic Asthma in the Italian Population
  Genes 2022 DOI: 10.3390/genes13020214
  +Save
• ADK-VR2, a cell line derived from a treatment-naive patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC
  Translational Lung Cancer Research 2022 DOI: 10.21037/TLCR-22-163
  +Save
• SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor
  Frontiers in Oncology 2022 DOI: 10.3389/FONC.2021.778461
  +Save
• Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion
  Blood 2021 DOI: 10.1182/blood.2021011677
  +Save